Continuous isoproterenol inhalation therapy in children with severe asthmatic attack

We studied the I-type isoproterenol inhalation therapy for patients with severe asthmatic attacks who were admitted at the Department of Allergy of National Children's Hospital from 1981 to 1991. One hour after I-type isoproterenol inhalation therapy statistically significant effects were noted with regard to the asthmatic status. Moreover no side effect was found amoung the subjects. From these data, I-type isoproterenol inhalation therapy is thought to be effective for severe asthmatic attacks.